Enzo Biochem Files Definitive Additional Proxy Materials
| Field | Detail |
|---|---|
| Company | Enzo Biochem Inc |
| Form Type | DEFA14A |
| Filed Date | Aug 8, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $1.05, $1.10, $0.60, $0.71, $0.32 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, shareholder-materials
TL;DR
Enzo Biochem dropped more proxy docs, shareholders need to pay attention.
AI Summary
Enzo Biochem, Inc. (Enzo) has filed definitive additional materials related to its proxy statement. The filing, dated August 8, 2025, concerns the company's proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. No fee was required for this filing.
Why It Matters
This filing indicates that Enzo Biochem is providing further information to shareholders regarding matters to be voted on at an upcoming meeting, which is crucial for shareholder engagement and corporate governance.
Risk Assessment
Risk Level: low — This is a routine SEC filing for additional proxy materials, not indicating any immediate financial or operational risk.
Key Players & Entities
- ENZO BIOCHEM, Inc. (company) — Registrant
- Enzo (company) — Abbreviated name for Enzo Biochem, Inc.
- 0001213900-25-073181.txt (document) — SEC Filing Accession Number
- August 8, 2025 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, which signifies Definitive Additional Materials for a proxy statement.
Who is the filing company?
The filing company is ENZO BIOCHEM, Inc.
What is the filing date?
The filing date is August 8, 2025.
Is this a preliminary or definitive proxy statement?
This filing is for Definitive Additional Materials, meaning it supplements a previously filed definitive proxy statement.
Was a fee required for this filing?
No fee was required for this filing.
Filing Stats: 4,475 words · 18 min read · ~15 pages · Grade level 11.2 · Accepted 2025-08-07 17:54:18
Key Financial Figures
- $1.05 — ity securities of the Company priced at $1.05 to $1.10 per share. The Battery LOI inc
- $1.10 — ities of the Company priced at $1.05 to $1.10 per share. The Battery LOI included a c
- $0.60 — d proposal to the Company at a price of $0.60 per share based upon, among other thing
- $0.71 — in the Company’s stock price from $0.71 on January 9, 2025 to $0.32 on April 11
- $0.32 — price from $0.71 on January 9, 2025 to $0.32 on April 11, 2025, as well as a challen
- $35 million — jority of the assets of the Company for $35 million. Parties A, C, D, and E offered email o
- $21.5 million — ncing, and the purchase price range was $21.5 million to $22 million. Party D provided a verb
- $22 million — rchase price range was $21.5 million to $22 million. Party D provided a verbal indication t
- $20 — that implied a preliminary valuation of $20-$25 million. The Special Committee perm
- $25 million — implied a preliminary valuation of $20-$25 million. The Special Committee permitted manage
- $31 — ubmitted were a purchase price range of $31 – $32 million and $45 – $55
- $32 million — e a purchase price range of $31 – $32 million and $45 – $55 million. The Specia
- $45 — ce range of $31 – $32 million and $45 – $55 million. The Special Commit
- $55 million — $31 – $32 million and $45 – $55 million. The Special Committee discussed these
- $0.65 — ed to provide an updated offer price of $0.65 per share, as well as revised drafts of
Filing Documents
- ea0251406-defa14a_enzobio.htm (DEFA14A) — 133KB
- 0001213900-25-073181.txt ( ) — 134KB
Forward-Looking Statements
Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This Supplement, filed pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this Supplement that are not statements of historical fact are hereby identified as “forward-looking